SBUX
40
-4
CAG
34
-2
APD
50
5
BWA
55
2
HRB
42
-4
MHK
45
2
NTAP
56
-3
GRMN
45
8
MRK
66
3
CMCSA
50
6
NI
67
2
FE
50
2
PEP
32
-3
AME
75
3
WM
60
3
ES
45
-4
EOG
37
4
CHD
35
-5
GD
64
2
HBAN
87
5
SBUX
40
-4
CAG
34
-2
APD
50
5
BWA
55
2
HRB
42
-4
MHK
45
2
NTAP
56
-3
GRMN
45
8
MRK
66
3
CMCSA
50
6
NI
67
2
FE
50
2
PEP
32
-3
AME
75
3
WM
60
3
ES
45
-4
EOG
37
4
CHD
35
-5
GD
64
2
HBAN
87
5
Financhill
Back

Biogen, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Sell
50

BIIB
Biogen, Inc.

Last Price:
$174.31
Seasonality Move:
8.72%
Sell
37

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$34.45
Seasonality Move:
-0.96%
Sell
50
Biogen, Inc. (BIIB) is a Sell

Is Biogen, Inc. a Buy, Sell or Hold?

  • The current Biogen, Inc. [BIIB] share price is $174.70. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $34.75. The Score for RARE is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIIB Stock Price Chart

What is Biogen, Inc.'s stock price today?

  • The Biogen, Inc. share price today is $174.70
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $34.75
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.17 Buy
Relative Strength Index (14 RSI): 54.66 Buy
Chaikin Money Flow: -343628 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (170.54 - 180.58) Sell
Bollinger Bands (100): (135.98 - 167.74) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.51 Buy
Relative Strength Index (14 RSI): 52.34 Buy
Chaikin Money Flow: 1445075 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.72 - 36) Buy
Bollinger Bands (100): (29.28 - 34.24) Buy

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 173.17 Buy
20-day SMA: 177.2 Sell
50-day SMA: 163.51 Buy
200-day SMA: 140.19 Buy
8-day EMA: 174.01 Buy
20-day EMA: 173.53 Buy
50-day EMA: 165.76 Buy
200-day EMA: 152.44 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.66 Buy
20-day SMA: 34.85 Sell
50-day SMA: 33.8 Buy
200-day SMA: 33.55 Buy
8-day EMA: 21.4 Buy
20-day EMA: 11.1 Buy
50-day EMA: 4.97 Buy
200-day EMA: 1.32 Buy

Biogen, Inc. Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.17 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

Biogen, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):